US5086068A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Immunochemical detection of hypoxia in normal and tumor tissue
Assignee: ALERTA CANCER BOARD
•
Filing: 1988-02-26
•
Granted: 1992-02-04
•
Expires: 2008-02-26
Abstract
Abstract A process for preparing an immunogenic conjugate of a nitroaromatic compound and a carrier comprises colavently bonding the nitroaromatic compound to the carrier in an essentially oxygen-free atmosphere and isolating the conjugate from the reaction mixture. The conjugate may be used to raise antibodies specific to the nitroaromatic hapten. The antibodies may be used to determine the presence of hypoxic tissue in living matter by treating the living matter with a nitroaromatic compound and subsequently testing suspected tissue to determine if there is binding of the antibody to tissue. By use of appropriate markers, bound antibodies can be determined to indicate the presence of hypoxic tissue due to the unique reaction of nitroaromatic compounds with hypoxic tissue.
Inventors
- 👤 James A. Raleigh
- 👤 Gerald G. Miller
- 👤 Allan J. Franko
- 👤 J. D. Chapman
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 12:45
CPC Classifications
A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/62; A61K47/64; A61K47/646; A61K47/54; A61K47/549
Claims Analysis
Total Claims: 17
Claim 1
Independent Claim
66 words
A process for preparing an immunogenic conjugate of a nitroaromatic compound covalently bonded to an immune response inducing carrier, said process comprising covalently bonding a nitroaromatic compound selected from the group consisting of nitrobenzenes, nitrofurans, nitrothiazoles, nitropyrroles, nitrodiazoles and nitrotriazoles, each of said nitroaromatic compounds having a side chain including an --NO 2 group, to said carrier in an essentially oxygen-free atmosphere and isolating said conjugate.
Claim 2
Dependent Claim
66 words
A process for preparing an immunogenic conjugate of a nitroaromatic compound covalently bonded to an immune response inducing carrier, said process comprising covalently bonding a nitroaromatic compound selected from the group consisting of nitrobenzenes, nitrofurans, nitrothiazoles, nitropyrroles, nitrodiazoles and nitrotriazoles, each of said nitroaromatic compounds having a side chain including an --NO 2 group, to said carrier in an essentially oxygen-free atmosphere and isolating said conjugate.
Claim 3
Dependent Claim
18 words
A process of claim 1, wherein said nitroaromatic compound is covalently bonded by reductive binding to said carrier.
Claim 4
Dependent Claim
26 words
A process of claim 1, wherein said reductive binding is effected by reducing said nitroaromatic compound using a chemical reducing agent, ionizing radiation, or reducing enzyme.
Claim 5
Dependent Claim
32 words
A process of claim 1, wherein said carrier is a protein, said nitroaromatic compound is reduced to include an hydroxylamine group which is covalently bonded to a sulfhydryl group of said protein.
Claim 6
Dependent Claim
36 words
A process of claim 1, wherein said nitroaromatic compound is selected from the group consisting of nitrobenzenes, nitrofurans, nitrothiazoles, nitropyrroles, and nitrotriazoles, each of said nitroaromatic compounds having a side chain including an --NO 2 group.
Claim 7
Dependent Claim
12 words
A process of claim 1, wherein said nitroaromatic compound is a 2-nitroimidazole.
Claim 8
Dependent Claim
13 words
A process of claim 6, wherein said 2-nitroimidazole is 1-(2-hydroxy-3-hexafluoroisopropoxy-propyl)-2-nitroimidazole, 1-[2-hydroxy-3-(2,2,2-trifluoroethoxy)propyl]-2-nitroimidazole or 1-(2-hydroxy-3-methoxypropyl)-2-nitroimidazole.
Claim 9
Dependent Claim
23 words
A process of claim 1, wherein said carrier is selected from the group consisting of proteins, deoxyribonucleic acid, ribonucleic acid, carbohydrates and lipids.
Claim 10
Dependent Claim
10 words
A process of claim 1, wherein said carrier is hemocyanin.
Claim 11
Dependent Claim
33 words
A process of claim 1, wherein said nitroaromatic compound is in solution at a concentration ranging from 10 to 1000 μmolar, and said carrier is at a concentration of 0.1 to 1.5 mg/ml.
Claim 12
Dependent Claim
23 words
A process of claim 10, wherein said solution includes 50 to 200 mmolar phosphate buffer at a pH ranging from 4 to 9.
Claim 13
Dependent Claim
47 words
A process of claim 3, wherein said nitroaromatic compound is a 2-nitroimidazole and said carrier is hemocyanin, reducing said 2-nitroimidazole in solution by radiating said solution with an ionizing radiation to produce electron donor components in solution which reduce said 2-nitroimidazole for covalent bonding to said hemocyanin.
Claim 14
Dependent Claim
13 words
A process of claim 12, wherein said 2-nitroimidazole is 1-(2-hydroxy-3-hexafluoroisopropoxy-propyl)-2-nitroimidazole, 1-[2-hydroxy-3-(2,2,2-trifluoroethoxy)propyl]-2-nitroimidazole or 1-(2-hydroxy-3-methoxypropyl)-2-nitromidazole.
Claim 15
Dependent Claim
45 words
An immunogenic conjugate comprising a nitroaromatic compound covalently bonded to an immune response inducing carrier, said nitroaromatic compound selected from the group consisting of nitrobenzenes, nitrofurans, nitrothiazoles, nitropyrroles, 2-nitroimidazoles and nitrotriazoles, each of said nitroaromatic compounds having a side chain including an --NO 2 group.
Claim 16
Dependent Claim
45 words
An immunogenic conjugate comprising a nitroaromatic compound covalently bonded to an immune response inducing carrier, said nitroaromatic compound selected from the group consisting of nitrobenzenes, nitrofurans, nitrothiazoles, nitropyrroles, 2-nitroimidazoles and nitrotriazoles, each of said nitroaromatic compounds having a side chain including an --NO 2 group.
Claim 17
Dependent Claim
24 words
An immunogenic conjugate of claim 14, wherein said carrier is selected from the group consisting of proteins, deoxyribonucleic acid, ribonucleic acid, carbohydrates and lipids.
References Cited (Backward Citations)
US4241060A
Cited
US4282232A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-02-03 | 1995-08-05 | 1996-02-04 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-02-03 | 1999-08-05 | 2000-02-04 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-02-03 | 2003-08-05 | 2004-02-04 | $7700.00 | Window Closed / Lapsed |